Customized data and analyses to address pharmaceutical and biotech pipeline or portfolio challenges
Evaluate Custom Solutions
Testimonials
“ Evaluate Custom Solutions paid careful attention to our report needs, and the after-care service was excellent, so our level of satisfaction was extremely high. It was one of the best services that I have experienced so far. ”
Motomu Himori, Specialist, Chugai Pharmaceutical Co., Ltd.
“ I really could not do my job without Evaluate data. You guys make me look good all the time. ”
Business Development & Licensing, Large Pharmaceutical
Our Work & Case Studies
Over the last year, 13 of the world’s largest pharmaceutical and biotech companies have engaged Evaluate Custom Solutions in addressing their biggest global challenges. These clients have engaged us to provide insight to help inform a range of their key objectives including: Market Analysis & Competitor Intelligence, Corporate Strategy & Franchise Planning, Market Expansion & Forecasting, Mergers & Acquisition, New Product Development, Market Access and Pricing & Commercialization.
Below are some examples of the work we have undertaken for the likes of Abbvie, Amgen, AstraZeneca, Bayer, Daiichi Sankyo, Gilead, GSK, Johnson & Johnson/Janssen, Merck KGaA, Novartis, Pfizer, Roche/Chugai and Sanofi.
Corporate Strategy Teams
An external industry perspective to complement your views on the market, competition, and your company's strategic direction.
Find out how a major global pharma gained an external perspective on market trends to support a key Executive Team strategy session.
R&D Strategy & Portfolio Planning
Objective, data-driven insights to validate if you are making the right choices for your product portfolio.
Find out how a Japanese pharma company benchmarked the R&D productivity of peer companies for insight into potential patterns and drivers.
Business Development & Licensing
Expedite your search and screen efforts and access robust, data-driven analysis to support opportunity assessment.
Find out how a mid-sized pharma BD&L team outsourced their search and screen efforts for a shortlist of assets with potential for licensing.
Commercial Operations, Pricing & Forecasting
Customized epidemiology research, forecast modelling, and pricing analysis to inform your product strategy and tactical planning.
Find out how a pharma commercial and finance group established a standard forecasting methodology across an entire business.
Digital & Data Science Teams
Feed industry-leading Evaluate commercial intelligence directly into your internal tools, systems and workflows via data feeds and APIs.
Find out how a major US pharma created a live M&A target screening tool by integrating Evaluate data into a data visualization dashboard.
Our Services
Our services are designed for teams defining product and portfolio strategy and setting direction for key brands and franchises. We provide insight into Market Analysis & Competitor Intelligence, Corporate Strategy & Franchise Planning, Market Expansion & Forecasting, Mergers & Acquisition, New Product Development, Market Access and Pricing & Commercialization.
Leveraging a foundation of extensive Evaluate data augmented with further secondary research, modelling, and analysis, our solutions are data-driven and insight-focused. We also conduct targeted primary research with Key Opinion Leaders, Healthcare Professionals and Payers to validate our assumptions and test our hypotheses.
Below we have provided an overview of our services and how they apply to the life stages of companies / products. Please click on the “+” to find out more. If there is something that is not listed here please contact us so we can work with you to get you the insights you need.
Discovery & Preclinical
Early Clinical Development (P1-P2a)
Late Clinical Development (P2b-P3)
Commercialisation
Market Analysis & Competitive Intelligence
Industry trend & growth driver analysis
Productivity & return on investment benchmarking
Indication landscape & evolution analysis
Competitor strategy profiling
Competitive landscape evolution and outlook
Epidemiology Modelling & Systematic Literature Review
Burden of illness & incidence/prevalence studies
Global/regional/country-specific patient segmentation modelling
Standard of care & treatment paradigm definition
Clinical outcomes & treatment pattern studies
Market sizing & unmet need identification
Oncology patient dynamic flow modelling
Rare disease epidemiology
Opportunity Identification & Quantification
Market profiling & segment analysis
Indication sizing, scoring & prioritisation
Competitive intensity analysis
Market opportunity analysis & forecasting
Opportunity identification, fit & prioritisation assessment
BD&L target search, screen & assessment
Partner identification & profiling
Deal benchmarking analysis
Product Strategy & Differentiation
Niche identification & addressable population sizing
Product positioning & differentiation assessment
Target product profile (TPP) definition & testing
Price benchmarking & sensitivity analysis
Scenario-based sales & volume forecast modelling
Product targeting & development strategy assessment
Data Feeds & APIs
Programmatic access to Evaluate data
Get in touch
Get in touch